AI eye teacher could revolutionize medical training

NCT ID NCT06759012

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 19, 2026 · Last updated Aug 20, 2026 · Updated 1 time

Summary

This trial tests whether an AI-powered virtual tutor called EyeTeacher can help medical students learn ophthalmology. About 269 students who have not yet taken eye care courses will be randomly assigned to use EyeTeacher or follow traditional teaching methods. Their knowledge will be compared through exams and questionnaires to see if the AI approach is as effective, and to explore its potential benefits and drawbacks.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
EyeTeacher, an AI-based virtual tutor for ophthalmology education
What this could lead to
If effective, EyeTeacher could offer a scalable, accessible way to teach medical students, potentially improving eye care education worldwide.
What could go wrong
This is an early-stage trial in a single field, and results may not apply broadly. AI performance can vary, and the system may not match traditional teaching in all settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

269 people

The number who actually took part.

Started

Mar 2025

Finished

Jul 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 to 40 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Clinical medical students who have not taken ophthalmology courses * Age 21-40 * Gender not restricted * Sign the informed consent form Exclusion Criteria: * Refusal of the research protocol. * Participants unwilling or unable to understand and complete the questionnaire.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Medical education are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • BenQ Medical Center, Nanjing Medical University Affiliated Hospital

    Nanjing, Jiangsu, 210019, China

  • Moorfields Eye Hospital

    London, EC1V 2PD, United Kingdom

  • Peking Union Medical College Hospital

    Beijing, Beijing Municipality, 430022, China

  • Sankara Nethralaya

    Chennai, Tamil Nadu, 600 006, India

  • University of Ghana

    Accra, Greater Accra Region, P.O. Box LG 586, Ghana

  • University of Malaya

    Kuala Lumpur, Kuala Lumpur, 50603, Malaysia

  • University of Melbourne

    Melbourne, Victoria, 3010, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.